⌘K

Login Start Free

Home/Filings/4/0001213900-23-047569

4//SEC Filing

Nolet Chris 4

Accession 0001213900-23-047569

CIK 0001788028other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 6:42 PM ET

Size

5.2 KB

Accession

0001213900-23-047569

Insider Transaction Report

Form 4

Period: 2023-06-07

Jasper Therapeutics, Inc.JSPR

Director

Transactions

Award
Stock Option (right to buy)
2023-06-07+47,000→ 47,000 total
Exercise: $1.60From: 2024-06-07Exp: 2033-06-07→ Voting Common Stock (47,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1

filerCIK 0001782814

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 6:42 PM ET
Size: 5.2 KB

View on SEC.gov